Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis

NCT00931411 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

73

Enrollment

INDUSTRY

Sponsor class

Stopped Patients would improve naturally due to weather conditions

Conditions

Atopic Dermatitis

Interventions

OTHER: Formulation 609580 20
OTHER: Formulation 609209 (Lipikar Baume)

Sponsor

Cosmetique Active International

Collaborators

[object Object]